Sulindac Sulfide, but Not Sulindac Sulfone, Inhibits Colorectal Cancer Growth
Sulindac sulfide, a metabolite of the nonsteroidal antiinflammatory drug (NSAID) sulindac sulfoxide, is effective at reducing tumor burden in both familial adenomatous polyposis patients and in animals with colorectal cancer. Another sulindac sulfoxide metabolite, sulindac sulfone, has been reporte...
Main Authors: | Christopher S. Williams, Angela P. Goldman, Hongmiao Sheng, Jason D. Morrow, Raymond N. DuBois |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1999-06-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S147655869980058X |
Similar Items
-
Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development
by: Jennifer S. Davis, et al.
Published: (2020-09-01) -
The effect of sulindac, a non-steroidal anti-inflammatory drug, attenuates inflammation and fibrosis in a mouse model of chronic pancreatitis
by: Bai Han, et al.
Published: (2012-08-01) -
Identification of the Effects of Aspirin and Sulindac Sulfide on the Inhibition of HMGA2-Mediated Oncogenic Capacities in Colorectal Cancer
by: Titus Ime Ekanem, et al.
Published: (2020-08-01) -
Radioprotective Potential of Sulindac Sulfide to Prevent DNA Damage Due to Ionizing Radiation
by: Torabizadeh SA, et al.
Published: (2019-12-01) -
Effects of betamethasone, sulindac and quinacrine drugs on the inflammatory neoangiogenesis response induced by polyurethane sponge implanted in mouse
by: JULIO ILLANES, et al.
Published: (2002-01-01)